PAR 16.7% 31.5¢ paradigm biopharmaceuticals limited..

It seems as though trials have been around for a long time but...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 46 Posts.
    lightbulb Created with Sketch. 9
    It seems as though trials have been around for a long time but no one has commercialised it yet. I found this "In the veterinary field from 1996 to date, there have been many studies and reports about the use of pentosan for OA [13,14]. Pentosan is now used worldwide. Ghosh and the Belgian study group conducted four small human studies in 1990s for OA of the knee, hip and fingers"

    It is from this article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873929/

    Seems to me that it is pretty clear that Pentosan works - I agree with you - I wonder why it has taken so long?
    Maybe we will be the lucky shareholders to reap the benefits (not to mention the patients who will gain MUCH more than money )
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
0.045(16.7%)
Mkt cap ! $82.30M
Open High Low Value Volume
27.5¢ 31.5¢ 27.5¢ $695.5K 2.362M

Buyers (Bids)

No. Vol. Price($)
2 23243 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 46000 4
View Market Depth
Last trade - 13.38pm 22/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.